Cholesterol, violence and suicidality - History of errors;Cholesterol, násilí a sebevražednost - Příběh plný omylů

Casopis Lekaru Ceskych

Volumn 145, Issue 2, 2006, Pages 118-125

  Vevera, Jan ^a,b   Zeman, Miroslav ^a   Smolik, Petr ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UK a FN ^*  (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cholesterol; Depression; Serotonin; Suicidality; Violence

Indexed keywords

CHOLESTEROL; SEROTONIN;

ARTICLE; HISTORY OF MEDICINE; HUMAN; HYPOTHESIS; MEDICAL ERROR; NONHUMAN; SUICIDAL BEHAVIOR; VIOLENCE; BLOOD; CLINICAL TRIAL; META ANALYSIS; REVIEW; SUICIDE;

CHOLESTEROL; HUMANS; SUICIDE; VIOLENCE;

EID: 33144472867     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Vevera, J.: Sebevražednost, impulsivita a terapie statiny. Čas. Lék. čes., 2004. 5, s. 360.
2. Vítek, L.: Statiny versus psychické poruchy. Čas. Lék. čes., 2004, 5, s. 361.
3. Vevera, J., Žukov, I., Morcinek, T., Papežová, H.: Cholesterol concentrations in violent and non-violent women suicide attempters. Eur. Psychiatry, 2003, 18, s. 23-27.
4. Žukov, I., Vevera, J., Morcinek, T.: Nižši hladiny cholesterolu u delikventů s afektivně násilným trestným činem v porovnání s delikventy bez násilného trestného činu a kontrolní skupinou. Čs. Psychiatrie, 2001, 97, s. 414-417.
5. Vevera, J., Papežová, H., Žukov, I., Linhartová, L.: Cholesterol a násilné chování . Cs. Psychiatrie, 2001, 97, s. 69-73
6. Tanskanen, A.: Violent suicide linked to high serum cholesterol levels. Am. J. Psychiatry, 2001, 157, s. 648-650.
7. Engelberg, H.: Low serum cholesterol and suicide. Lancet, 1992, 339, s. 727-729.
8. Kaplan, J., Manuck, S., Shively, C.: The effects of fat on cholesterol on social behaviour in monkeys. Psychosom. Medicine, 1991, 53, s. 634-642.
9. Muldon, M., Kaplan, J., Manuck, S., Mann, J.: Effects of of a low fat diet on brain serotonergic responsivity in cynomologus monkeys. Biol. Psychiatry, 1992, 31, s. 739-742.
10. Kaplan, J., Shinely, C., Fontenot, B. et al.: Demonstration of an association among dietary cholesterol, central serotonergic activity and social behavior in monkeys. Psychosom. Medicine, 1994, 56, s. 479-484.
11. Heron, D. S., Shinitzky, M., Hershkowitz, M., Samuel, D.: Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. USA, 1980, 77, s. 7463-7467.
12. Hershkowitz, M., Heron, D., Samuel, D., Shinitzky, M.: The modulation of protein phosphorylation and receptor binding in synaptic membranes by changes in lipid fluidity: implications for ageing. Prog. Brain. Res., 1982, 56, s. 419-434.
13. Muldoon, M., Barger, S., Ryan C. et al.: Effects of lovastatin on cognitive function and psychological well-being. Am. J. Med., 2000, 108, s. 538-547.
14. Fernstrom, M. H., Verrico, C. D., Ebaugh, A. L., Fernstrom, J. D.: Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brain. Life Sci., 1996, 58, s. 1433-1444.
15. McCreary, A., Handley, S. L.: Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats. J. Psychopharmacol., 2000, 14, s. 280-283.
16. Morita, I., Sato, I., Ma, L., Murota, S.: Enhancement of membrane fluidity in cholesterol-poor endothelial cells pre-treated with simvastatin. Endothelium, 1997, 5, s. 107-113.
17. Vevera, J., Fišar, Z., Kvasnička, T. et al.: Cholesterol lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatric Research, 2005, 133, s. 197-203.
18. Scanlon, S. M., Williams, D. C., Schloss, P.: Membrane cholesterol modulates serotonin transporter activity. Biochemistry, 2001, 3, s. 10507-10513.
19. Hibbeln, J. R., Umhau, J. C., George, D. T., et al.: Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids. Am. J. Clin. Nutrition, 2000, 71 (Suppl. 1), s. 331S-338S.
20. Engstrom, G., Alsen, M., Regnell, G., Traskman-Bendz, L.: Serum lipids in suicide attempters. Suicide and Life Threating Behavior, 1995, 25, s. 393-400.
21. Ringo, D. L., Lindley, S. E., Faull, K. F., Faustman, W. O.: Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol. Psych., 1994, 35, s. 957-959.
22. Virkkunen, M., Eggert, M., Rawlings, R., Linnoila, M.: A prospective follow-up study of alcoholic violent offenders and fire setters. Archives of Gen. Psych., 1996, 53, s. 523-529.
23. Eriksson, M., Eklundh, T., Sjoberg, S. et al.: Cholesterol lowering and cerebrospinal fluid neurotransmitters: increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers. Biol. Psychiatry, 1996, 40, s. 302-304.
24. Terao, T., Nakamura, J., Yoshimura, R. et al.: Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women. Psychiatry Res., 2000, 96, s. 167-173.
25. Terao, T., Yoshimura, R., Ohmori O. et al.: Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biol. Psychiatry, 1997, 41, s. 974-978.
26. Delva, N. J., Matthews, D. R., Cowen, P. J.: Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs. Biological Psychiatry, 1996, 39, s. 100-106.
27. Sarchiapone, M., Camardese, G, Roy A. et al.: Cholesterol and serotonin indices in depressed and suicidal patients. J. Affect Disord., 2001, 3, s. 217-219.
28. Buydens-Branchey, L., Branchey, M., Hudson, J., Fergeson P.: Low HDL cholesterol, aggression and altered central serotonergic activity. Psychiatry Research, 2000, 93, s. 93-102.
29. Steegmans, P. H., Hoes, A. W., Bak, A. A. et al.: Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosomatic Medicine, 2000, 62, s. 205-211.
30. Alvarez, J. C., Cremniter, D., Lesieur, P. et al.: Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol. Psychiatry, 1999, 45, s. 1066-1069.
31. Krikava, K., Kalla, K., Yamamotova, A., Rokyta, R.: Blood serum changes in patients with pain during bone fractures and acute pancreatitis. Neuroendocrinology Letters, 2004, 25, s. 62-69.
32. Hillbrand, M., Foster, H.: Serum cholesterol levels and severity of aggression. Psychological Reports, 1993, 2, s. 270.
33. Peet, M., Murphy, B., Shay, J., Horrbin, D.: Depletion of omega 3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry, 1998, 43, s. 315-319.
34. Peet, M.: International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis Br. J. Psychiatry, 2004, 184, s. 404-408.
35. Seidman, S. N., Araujo, A. B., Roose, S. P., McKinlay, J. B.: Testosterone level, androgen receptor polymorphism, and depression symtoms in middle-aged men. Biol. Psychiat, 2001, 50, s. 371-376.
36. Allolio, B., Arlt, W.: DHEA treatment: myth or reality? Trends in Endocrinology and Metabolism 2002, 13, s. 288S-294S.
37. Hyyppa, M. T., Kronholm, E., Virtanen, A. et al.: Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology, 2003, 28, s. 181-194.